| Total | Low | High | p value |
---|---|---|---|---|
 |  | n (%) | n (%) |  |
Gender | ||||
Males | 78 | 42 (54) | 36 (46) | Â |
Females | 59 | 26 (44) | 33 (56) | n.s. |
Age (yr) | ||||
≤68 | 73 | 33 (45) | 40 (55) |  |
>68 | 64 | 34 (54) | 29 (46) | n.s. |
Tumor Grading | ||||
1 | 9 | 3 (33) | 6 (67) | Â |
2 | 86 | 45 (52) | 41 (48) | Â |
3 | 42 | 20 (48) | 22 (52) | n.s. |
pT parameter | ||||
pT1 | 12 | 7 (58) | 5 (42) | Â |
pT2 | 17 | 7 (41) | 10 (59) | Â |
pT3 | 75 | 35 (47) | 40 (53) | Â |
pT4 | 33 | 19 (58) | 14 (42) | n.s. |
Nodal status | ||||
Negative | 76 | 37 (49) | 39 (51) | Â |
Positive | 61 | 31 (51) | 30 (49) | n.s. |
Tumor stage | Â | Â | Â | Â |
I | 25 | 11 (44) | 14 (56) | Â |
II | 43 | 18 (42) | 25 (58) | Â |
III | 69 | 39 (56) | 30 (44) | n.s. |
Recurrence | ||||
YES | 57 | 34 (60) | 23 (40) | Â |
NOT | 80 | 34 (42) | 46 (58) | 0.035 |
Follow-up | ||||
Deceased | 51 | 32 (63) | 19 (37) | Â |
Alive | 86 | 36 (42) | 50 (58) | 0.014 |